171 – 180 of 317
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Von Willebrand disease prophylaxis network
(
- Contribution to journal › Published meeting abstract
-
Mark
European Initiative to prevent joint damage in haemophilia children with inhibitors (ENJOIH) - a prospective study
(
- Contribution to journal › Published meeting abstract
-
Mark
Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay (VWF:RCo) using a novel automated assay protocol
(
- Contribution to journal › Published meeting abstract
-
Mark
A retrospective study: of Octaplex (R) in the treatment of bleeding in patients with haemophilia A complicated by inhibitors
(
- Contribution to journal › Published meeting abstract
-
Mark
The role of prophylaxis in bleeding disorders
(
- Contribution to journal › Scientific review
-
Mark
Knowledge of disease and adherence in adult patients with haemophilia.
(
- Contribution to journal › Article
-
Mark
Physical activity for prevention of osteoporosis in patients with severe haemophilia on long-term prophylaxis.
(
- Contribution to journal › Article
-
Mark
Reply to 'Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors' (Haemophilia 2009; 15: 3-10).
(
- Contribution to journal › Article
-
Mark
The optimal mode of delivery for the haemophilia carrier expecting an affected infant is vaginal delivery.
(
- Contribution to journal › Article
-
Mark
Thrombin generation in vitro in the presence of by-passing agents in siblings with severe haemophilia A.
(
- Contribution to journal › Article